Daniel Perez was named President of Hinge Health, Inc., succeeding James Pursley. As of November 4, 2026, Hinge Health, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on November 2, 2026, naming 2 appointments and 1 departure (Form 8-K, November 2, 2026).
Sell to companies like Hinge Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Out · Person: James Pursley · Role: President · Effective: 2027-01-01 · 8-K, 2026-11-02
- · In / out: In · Person: James Pursley · Role: Director · Effective: 2027-01-04 · 8-K, 2026-11-02
- · In / out: In · Person: Daniel Perez · Role: President · 8-K, 2026-11-02
Hinge Health, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-11-02. It names 2 people, with 2 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Hinge Health, Inc. files it.
Also on the record for Hinge Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by Deer X & Co. L.P. | 3% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Insight Venture Associates X, L.P. | 9.4% of the class | 5%+ stakes | Source |
| August 13, 2026 | Stake report, Schedule 13G/A, by Qian Zhuang | 4% of the class | 5%+ stakes | Source |
| July 28, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.5% of the class | 5%+ stakes | Source |
| June 8, 2026 | Stake report, Schedule 13G/A, by Atomico Advisors IV, Ltd. | 2.88% of the class | 5%+ stakes | Source |
| April 27, 2026 | Stake report, Schedule 13G, by HANSAINVEST Hanseatische Investment-Limited Co | 2.7% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 9, 2026 | Stake report, Schedule 13G/A, by Atomico Advisors IV, Ltd. | 5.1% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Coatue Management, L.L.C. | — | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Deer X & Co. L.P. | 8.3% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Alkeon Capital Management LLC | 2.1% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Daniel Antonio Perez | 15.7% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Hinge Health, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Hinge Health, Inc. and the records around it.
Hinge Health, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Companies that share a holder
- Alkeon Capital Management LLC also filed stake reports on 1 other company: Oric Pharmaceuticals, Inc. (Nov 2025)
- HANSAINVEST Hanseatische Investment-Limited Co also filed stake reports on 1 other company: Iris Energy Ltd (Jul 2025)
- Insight Venture Partners X, LP also filed stake reports on 2 other companies: Coursera, Inc. (Aug 2026), Hawkeye 360, Inc. (Aug 2026)
Watch Hinge Health, Inc.
Get an email when Hinge Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Hinge Health, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Hinge Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Hinge Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 34 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-11-02 | Out | President | 2027-01-01 | 8-K, 2026-11-02 | |
| 2026-11-02 | In | Director | 2027-01-04 | 8-K, 2026-11-02 | |
| 2026-11-02 | In | President | 8-K, 2026-11-02 |
Who leads Hinge Health, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: James Pursley, appointed, effective 2027-01-04 (filed 2026-11-02).
- President: James Pursley, departure reported, effective 2027-01-01 (filed 2026-11-02). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Hinge Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President at Hinge Health, Inc., with the record behind each one.
Find candidates like President at Hinge Health, Inc.Every change, in the filing's words
Departing: James Pursley, President, effective 2027-01-01
On October 29, 2026, James Pursley notified the Company of his intention to resign as President of the Company, effective January 1, 2027 (the "Resignation Date").
Appointed: James Pursley, Director, effective 2027-01-04
On October 29, 2026, following a recommendation by the Nominating and Corporate Governance Committee of the Board of Directors of the Company (the "Board"), the Board increased its size from six to seven directors and appointed Mr. Pursley to serve as a member of the Board, in each case effective January 4, 2027.
Appointed: Daniel Perez, President
The foregoing description of the Advisor Agreement does not purport to be complete and is qualified in its entirety by reference to the Advisor Agreement, which is filed as Exhibit 10.1 to this Form 8-K. Appointment of Daniel Perez as President In connection with Mr. Pursley's resignation, on October 29, 2026, the Board appointed Daniel Perez, the Company's Co-Founder and Chief Executive Officer, to also serve as President of the Company, effective as of the Resignation Date.
- Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
- Mr. Pursley's decision to resign was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- Mr. Pursley will assist with the transition of his responsibilities ahead of the Resignation Date.
- The Company is grateful for Mr. Pursley's contributions to the Company.
- Starting January 4, 2027, Mr. Pursley will serve as a Class II director, with a term expiring at the Company's annual meeting of stockholders to be held in 2027, and until Mr. Pursley's successor shall have been duly elected and qualified, or until his earlier death, resignation, disqualification or removal.
- Mr. Pursley will be eligible to receive the annual cash retainer payable to non-employee directors under the Company's Non-Employee Director Compensation Program (the "Director Compensation Program").
- Consistent with the Director Compensation Program, Mr. Pursley will receive an annual cash retainer of $40,000 for his service on the Board.
Tools for this story
Each opens in a new tab, filled in for Hinge Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.